Biophysical techniques are described for the large-scale isolation of Australia antigen (Au) from unit quantities of human serum by using the batch-type zonal centrifuge rotors. A three-step procedure involving isopycnic banding of the particle in CsCl density gradients and rate-zonal centrifugation on sucrose gradients resulted in a highly purified Au preparation which was used for biochemical studies of Au proteins and as immunizing antigen for the production of reagent antiserum in animals. The spherical form of Au, which was devoid of detectable nucleic acid, was composed of two major proteins (AuPi and AuP2) and a minor protein (AuP3) of 26,000, 32,000, and 40,000 molecular weight, respectively, as determined by acrylamide gel electrophoresis. The significance of these findings to the possibility of Au subtypes is discussed.
Australia (hepatitis-associated) antigen is located on a particle 20 to 25 nm in diameter and is closely associated with serum (long-incubation or type B) hepatitis. Although it has not yet been established that Australia antigen (Au) is an infectious agent, its presence in blood known to transmit the disease and in the acute-phase serum specimens from patients with long-incubation hepatitis has been repeatedly demonstrated (2, 4, 8, 9, 12, 15) . This high correlation between Au and type B hepatitis has definite value in clinical diagnosis and for epidemiological studies of the disease. Recently described sensitive serological techniques (14, 16, 17, (20) (21) (22) for the detection of Au have important application in the screening of human blood and blood products intended for human parenteral administration.
Large quantities of well characterized and highly purified antigen are needed for biochemical studies of the antigen particle and for the production of high-titered and specific animal antiserum to Au for the standardization of the various serological techniques.
This report describes in detail procedures for ' the preparation of purified Australia antigen by using the large capacity batch-type zonal centrifuge rotors. Au prepared by these procedures was used as immunizing antigen for the production of reference reagents for Australia antigen (Research Resources Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health) and for biochemical characterization of the Au particle. Studies of Australia antigen proteins by acrylamide gel electrophoresis are contained in this report.
MATERIALS AND METHODS Source of Australia antigen. The sera from three units of Au-positive blood obtained by plasmapheresis of a young adult female (J. M) with chronic anicteric hepatitis were stored frozen at -70 C until used for purification of Au.
Zonal centrifugation: B-XXIX rotor. The Oak Ridge B-XXIX, an edge-unloading titanium rotor with a capacity of 1,430 ml, was used for the concentration and purification of Au from serum. The rotor and basic operating procedures were previously described (1). All centrifugation steps were done with the Beckman model L equipped with an fw2dt integrator.
Reagents. Cesium chloride (American Potash and Chemical Corp.) was purified as previously described (23) . CsCl solutions in 0.01 M phosphate buffer (pH 7.4) were made by dilution of a stock saturated 569 GERIN, HOLLAND, AND PURCELL solution of CsCl in water. Sucrose solutions were prepared by dissolving crystals (Mallinckrodt, analytical reagent grade) in 0.01 NI phosphate buffer (pH 7.4) with gentle mixing without warming. All solutions were filtered through 0.22-,im diameter membrane filters (Millipore Corp., Bedford, Mass.) and tested for sterility before use.
First-step isopycnic banding. The first step of purification was achieved by the isopycnic banding of Au in discontinuous CsCl gradients in two parts: the first centrifugation with serum from one unit (250 ml) of J. M. as starting sample and a second with two units (5C0 ml). In the first experiment, the empty rotor, while rotating at 2,500 rev/min, was loaded from the rotor periphery with one unit of serum diluted to 400 ml with phosphate-buffered saline (PBS; 0.15 NI NaCl, 0.01 M phosphate buffer, pH 7.4) followed sequentially by 400 ml of 1.10 g/cm3 CsCl, 250 ml of 1.20 g/cm3 CsCl, 200 ml of 1.30 g/cm3 CsCl, and 180 ml of 1.40 g/cm3 CsCl. A 100-ml amount of PBS was then pushed into the rotor through the center line with a syringe, thereby displacing a like volume of 1.40 g/cm3 CsCl cushion from the periphery. The rotor was accelerated to 25,000 rev/min run for 11 hr at 5 C, and allowed to coast without braking to 2,500 rev/min (58.5 X l100 cw2t). The gradient was displaced from the rotor edge by pumping sterile distilled water to the rotor center at about 20 ml/min and 36 40-ml fractions were collected by hand.
For the second experiment, 500 ml of serum diluted to 700 ml with PBS, followed sequentially by 200 ml of 1.10 g/cm3 CsCl, 200 ml of 1.30 g/cm3 CsCl, and 330 ml of 1.40 g, cm3 CsCl, was pumped into the empty rotor from the periphery with the rotor rotating at 2,500 rev/min. An overlay of 150 ml of PBS was then introduced into the rotor through the center line; the rotor was accelerated to 30,000 rev/min and run for 87.5 X 10'°%2t at 5 C. The gradient was displaced and collected as described above.
Second-step isopycnic banding. Fractions containing Au from both of the first-step banding experiments described above were pooled and used as the starting sample for the second-step purification. A 250-ml amount of 1.10 g/cm3 CsCl followed in order by 330 ml of starting sample at a density of 1.20 g/cm3 CsCl, 300 ml of 1.30 g/cm3 CsCl, and 550 ml of 1.40 g/cm3 CsCl was pumped into the empty rotor rotating at 2,500 rev/min. Two hundred milliliters of PBS was introduced through the center line as an overlay solution. The rotor was accelerated to 28,000 rev/min and run at 5 C for 22 hr (146 X 10l°w2t). The gradient was displaced and collected as described above except that the effluent stream was monitored in the Gilford model 240 spectrophotometer at 280 nm with an Oak Ridge flow cell with a 0.2-cm light path.
Rate zonal separation. The B-XXIX rotor was loaded at 2,500 rev/min with a linear 1,000-ml 7 to 251nj7 (w/w) sucrose gradient generated from a Beckman 142 gradient pump followed by 430 ml of 50% (w/w) sucrose cushion. The starting sample as described in the text was injected into the center of the rotor with a 50-ml syringe and was followed by a PBS overlay. The rotor was accelerated to 28,000 rev/min, run for the period of time described in the text at 5 C, and decelerated to 2.500 rev/min to unload the gradient. The gradient was displaced from the rotor periphery by pumping water to the center, and the effluent was monitored for absorbancy at 280 nm by using an Oak Ridge flow cell with a 1-cm light path in a Gilford model 240 spectrophotometer. Thirty-six 40-ml fractions were collected and stored at 4 C until assayed for sucrose concentration and Au antigen activity.
Sedimentation coefficients. Equivalent sedimentation coefficients (S*,) were determined with the aid of the computer program developed at the Oak Ridge National Laboratory (3). Values of S* were determined for every fraction from the recovered gradient for particles with densities of 1.14, 1.16, 1.18, and 1.20 g/cm3 in sucrose. Density determination. The density of individual fractions was determined either by direct weighing in tared 100 pliter micropipettes or from curves relating refractive index to density. Refractive indexes were read at 20 C with an Abbe 3L-type refractometer.
Optical density measurements. Those fractions of the gradient from the second-step banding experiment which had optical density values beyond the range of the spectrophotometer were diluted and read manually against a PBS blank in a Gilford 2400 spectrophotometer. These values were multiplied by the dilution factor to give the values shown in the appropriate figure. The ultraviolet absorption curve of the final purified Au was determined manually at 5-to 10-nm intervals in a 0.3-ml microcuvette with a light path of 1 cm against a PBS blank.
Acrylamide gel electrophoresis. Acrylamide, 2-mercaptoethanol (2-ME), and sodium dodecyl sulfate (SDS) were (5) . Destaining was carried out in 10%" trichloroacetic acid for 4 hr, and the gels were scanned at 550 nm by using the linear transport accessory of the Gilford 2400 spectrophotometer. SDS-urea-pH 7.6 gels were a modification of those used by Maizel (11) , had an acrylamide concentration of 10>'/ with a bis:acrylamide ratio of 1:50, and contained 0.1%C SDS, 0.1 M phosphate buffer (pH 7.6), and 4 M urea. The electrode buffers contained 0.1% SDS and 0.1 M phosphate buffer, pH 7.6; the upper buffer also contained 1% 2-ME.
Twenty-five-or 50-pliter samples were applied by underlayering. and the gels were electrophoresed for 4 hr at 5 ma/gel. Gels were fixed as described above except that the 12.5% trichloroacetic acid was replaced by a 5%O trichloroacetic acid plus 5%O sulfosalicylic acid mixture as suggested by Chrambach et al. (5) .
CF. Au was monitored during purification by using a Microtiter complement fixation (CF) test for Au which was described in a previous communication (16) . Serum containing antibody to Au was obtained from a multiply transfused patient with hepatitis and was heated to 56 C for 30 min to destroy endogenous complement; purified Au was tested without prior heat inactivation. Four to 8 units of antibody and 1.7 exact units of complement were used in the test; antigen-antibody-complement mixtures were incubated overnight at 4 C before the addition of sensitized sheep erythrocytes.
Electron microscopy. Preparations of purified Au were examined in a Hitachi HU-l1 E electron microscope at an instrumental magnification of 50,000 and 90,000 X after negative staining with 2% uranyl acetate.
RESULTS
Isolation of Australia antigen from serum. Purification of Au achieved by the first-step isopycnic banding procedure resulted from the concentration of the complement-fixing antigen in a single zone of activity at a density of 1.20 g/cm3 in CsCI (Fig. 1) . When 500 ml of J.M. (CF titer = 1:4,096) was used as the starting sample, the peak 40-ml fraction recovered from the gradient ( recovery of Au activity. The Au-positive fractions from both first-step banding procedures were pooled and used as the starting sample for the second-step isopycnic banding experiment; this pool was designated JMCsl.
Second-step banding of Au in CsCI resulted in further purification as shown in Fig. 2 ; the antigen was fully recovered in a very sharp zone at a density of 1.20 g/cm3 well removed from the bulk of the contaminating serum proteins. The peak fraction and one fraction on either side of the peak were pooled; this 120-ml pool was designated JMCs2.
The third-step purification procedure consisted of a rate zonal centrifugation of the Au particles. The removal of CsCl from JMCs2 pool was accomplished by either dialysis at 4 C against PBS or exchange of CsCl by PBS by using the Amicon Diaflo apparatus with an XM-50 membrane at 50 psig of nitrogen pressure; both techniques worked equally well and there was no loss of Au CF antigen activity. In a preliminary experiment, 10 ml of JMCs2 was diluted to 30 ml with PBS and was used as the starting sample for the rate zonal centrifugation. This sample was introduced into the rotor, followed by a 150-ml PBS overlay; the rotor was accelerated to 28,000 rev/min and centrifuged for 3 hr at 5 C (10.3 X 1010 W2t). Assuming a particle density of 1.16-g/cm3 in sucrose (7), Au sedimented as a discrete zone with an equivalent S* value of 52 (Fig. 3) . However, Au was not clearly resolved from the contaminat- (16) .
Estimation of purity. The purification of Au during the various steps of the above described procedure was evaluated by disc electrophoresis on acrylamide gels, a sensitive technique for the detection of serum proteins. Each of the pools representing different stages in the purification (i.e., JMCsl, JMCs2, and JMCs2R1) were adjusted to the same concentration of Au present in the original J.M. serum. The Au particle itself 2.0r- will not enter the 7.5% gel; however, except for some macroglobulins, unaggregated serum proteins will migrate in a characteristic manner. Absorption scans of stained gels (Fig. 5A-5D ) demonstrated the extensive purification achieved by the p-s procedures. After the second-step isopycnic banding in CsCl (Fig. SC) , the major remaining serum contaminant was albumin, albeit at a much lower concentration than in the original J.M. serum (Fig. SA) . The final rate zonal step removed all traces of serum proteins detectable by this technique (Fig. 5D ). Attempts to detect human serum proteins in the JMCs2R1 preparation by immunoelectrophoresis were also unsuccessful (H. Alter, personal communication).
Aseptic techniques were employed throughout the purification procedure, and the final pool of antigen was sterile by routine assay. The large quantity of highly purified Au was used for further biochemical studies and as immunizing antigen for the preparation of a large pool of high-titered animal antiserum. A guinea pig antiserum (V801-501-058) was Ultraviolet absorption spectrum. An ultraviolet absorption spectrum of the material in the peak Au fraction from the rate zonal step shown in Fig.  4 was characteristic of protein with a maximum and minimum of 280 and 250 nm, respectively (Fig. 6) . The OD 260/280 ratio of 0.67 argues against the presence of nucleic acid in the spherical form of the Au, certainly below the level of one genome per particle.
Electron microscopy of JMCs2R1 revealed only spherical forms of Au, and careful measurements of 100 particles yielded an average diameter of 22 nm (range 21 to 23 nm).
Proteins of Australia antigen. Samples of the JMCs2 and JMCs2R1 pools adjusted to the same concentrations of Au were diluted fivefold with distilled water and pelleted by overnight centrifugation at 40,000 rev/min in the Spinco 50 Ti rotor. Samples of Au for electrophoresis on SDSurea (pH 7.6) gels were prepared by resuspending the pellets in a solution of 0.1 M phosphate buffer (pH 7.6), 1%6/ SDS, 6 M urea, and 1%', 2-ME to contain 2 mg/ml and were solubilized by heating to 60 C for 10 min.
Two major polypeptides (AuPl and AuP2) of approximately equal concentration were evident in both of the Au-containing pools (Fig. 7) , and a third minor protein, tentatively designated AuP3, was consistently observed. Protein markers (bovine serum albumin, bovine serum albumin dimer, chymotrypsinogen A, and cytochrome c) were run on separate gels in the same experiment, and, from the plot of log molecular weight versus relative migration (19) with regard to the bromophenol blue tracking dye (Fig. 8) MIw serum This not detectable by immunodiffusion because of its using internal low concentration merits further study. The presprograms as-ence of two or more distinct antigens associated with a particle with the particle known as Australia antigen cerot account for tainly raises questions concerning nomenclature. VOL. 7, 1971 Animal and human antiserum intended for the large scale screening of donor blood units and prepared against mixtures of Australia antigens with undefined antigenic determinants would be difficult to standardize for use as a reagent. The two or more antigens associated with the particle may differ in their potency as immunogens and antisera could be expected to vary widely in their ability to detect a given specificity by any given assay system. Such variations beitween antisera have been repeatedly noted in a number of laboratories. The preparation of an antiserum pool from adjusted subpools of monospecific antiserum of known potency would seem the more satisfactory approach to the problem of standard working reagents.
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